We have shown that the Mini rat, a transgenic rat strain carrying the antisense transgene for rat growth hormone, is a useful model to investigate the role of growth hormone in the expression of hepatic microsomal cytochrome P450s (CYPs). However, the induction of CYP isoforms by hepatic enzyme inducers in Mini rats has not been investigated. We selected two enzyme inducers, 3-methylcholantherene (2 mg/kg/day, i.p.) and phenobarbital (5 mg/kg/day, p.o.), and administered them to male Mini rats and their parental strain, Wistar rats, for 3 days. Enzyme activity assays and immunohistochemistry showed no differences in the expressions of CYP1A and CYP2B between untreated Wistar and Mini rats. 3-Methylcholanthrene administration induced CYP1A in both strains, but the induction was significantly higher in the Mini rat liver than in the Wistar rat liver. Phenobarbital administration increased CYP2B activity in both strains by more than 20-fold over their respective controls. Although there was no difference in the CYP2B immunohistochemistry between the two strains given phenobarbital, the CYP2B activity of phenobarbital-treated Mini rats was significantly higher than that of phenobarbital-treated Wistar rats. These results suggest that growth hormone may play a role in the hepatic enzyme induction. Cytochrome P450s (CYPs) are a family of enzymes responsible for metabolism of drugs and steroids. It is well known that the expressions of several CYP isoforms show sexual dimorphism depending on the secretory patterns of blood growth hormone (GH). For example, the expressions of CYP2C11 1 , CYP3A2 2 , 3 and CYP2A2 3 , so-called masculine isoforms of CYPs, are regulated by the malespecific intermittent blood GH pattern with 3-to 4-hr intervals. On the other hand, the expressions of several CYP isoforms, including CYP2E1 and CYP2B1/2B2, are enhanced when blood GH is depleted 4,5 . Mini:Nts rats, Jcl:Wistar-TgN(ARGHGEN)1Nts rats 6 or Mini rats 7 , are a recently developed transgenic rat strain based on Wistar/Jcl (Wistar) rats carrying the antisense transgene for rat GH 7, 8 , resulting in lower blood GH level and retarded growth 7, 9 . We have previously shown that the total CYP contents and protein production and activity of CYP2C11 and CYP3A2 are lower in the hepatic microsomes of untreated Mini rats than in those of untreated Wistar rats, whereas the expression of CYP2E1 is higher in the former than in the latter strain 10 . However, the induction of hepatic drug metabolizing enzymes by hepatic enzyme inducers in Mini rats has not been investigated. Prior to this study, we administered 3-methylcholathrene (3-MC, CYP1A inducer), phenobarbital (PB, CYP2B inducer) or pregnenolone-16α-carbonitrile (PCN, CYP3A inducer) for 3 days or acetone (CYP2E1 inducer) for 10 days to male Wistar rats and Mini rats at a wide range of doses. All hepatic enzyme inducers induced activities of respective CYP isoforms in a doserelated manner and the magnitudes of induction were larger in Mini rats for all the isoforms tested, especially for CYP1A and CYP2B (not shown). In this study, we therefore expected to show strain differences in the enzyme induction of CYP1A and CYP2B in male Wistar rats and Mini rats by the administrations of 3-MC and PB using activity assays and immunohistochemistry.
Cytochrome P450s (CYPs) are a family of enzymes responsible for metabolism of drugs and steroids. It is well known that the expressions of several CYP isoforms show sexual dimorphism depending on the secretory patterns of blood growth hormone (GH). For example, the expressions of CYP2C11 1 , CYP3A2 2 , 3 and CYP2A2 3 , so-called masculine isoforms of CYPs, are regulated by the malespecific intermittent blood GH pattern with 3-to 4-hr intervals. On the other hand, the expressions of several CYP isoforms, including CYP2E1 and CYP2B1/2B2, are enhanced when blood GH is depleted 4, 5 . Mini:Nts rats, Jcl:Wistar-TgN(ARGHGEN)1Nts rats 6 or Mini rats 7 , are a recently developed transgenic rat strain based on Wistar/Jcl (Wistar) rats carrying the antisense transgene for rat GH 7, 8 , resulting in lower blood GH level and retarded growth 7, 9 . We have previously shown that the total CYP contents and protein production and activity of CYP2C11 and CYP3A2 are lower in the hepatic microsomes of untreated Mini rats than in those of untreated Wistar rats, whereas the expression of CYP2E1 is higher in the former than in the latter strain 10 . However, the induction of hepatic drug metabolizing enzymes by hepatic enzyme inducers in Mini rats has not been investigated. Prior to this study, we administered 3-methylcholathrene (3-MC, CYP1A inducer), phenobarbital (PB, CYP2B inducer) or pregnenolone-16α-carbonitrile (PCN, CYP3A inducer) for 3 days or acetone (CYP2E1 inducer) for 10 days to male Wistar rats and Mini rats at a wide range of doses. All hepatic enzyme inducers induced activities of respective CYP isoforms in a doserelated manner and the magnitudes of induction were larger in Mini rats for all the isoforms tested, especially for CYP1A and CYP2B (not shown). In this study, we therefore expected to show strain differences in the enzyme induction of CYP1A and CYP2B in male Wistar rats and Mini rats by the administrations of 3-MC and PB using activity assays and immunohistochemistry.
3-MC and glucose-6-phosphate dehydrogenase (G6PDH) were purchased from Wako Pure Chemical Industries (Osaka, Japan). PB was purchased from Fujinaga P h a r m a c e u t i c a l ( T o k y o , J a p a n ) . R e s o r u f i n , 7 -ethoxyresorufin (7-ER), 7-pentoxyresorufin (7-PR), β-NADPH and glucose-6-phosphate (G6P) were purchased from Sigma Chemical (St. Louis, MO). Primary antibodies for CYP1A1 and CYP2B1 were purchased from Daiichi Pure Chemicals (Tokyo, Japan). Biotinylated rabbit antibody for goat IgG was purchased from DAKO (Glostrup, Denmark). Streptavidin-conjugated horseradish peroxidase was purchased from Nichirei (Tokyo, Japan). Other chemicals used were of biochemical grade or the highest grade commercially available.
Male Wistar rats (CLEA Japan, Shizuoka, Japan) and Mini rats (Nippon Institute for Biological Science, Tokyo, Japan) were used at 7 weeks of age. The animals were housed in stainless steel cages (5 rats per cage) with sterile sawdust for bedding in a specific pathogen-free facility in our laboratories and allowed free access to commercial chow F-2 (Funabashi Farm, Chiba, Japan) and filtered tap water during both acclimating and experimental periods. The guidelines used in the present study were provided by the Institutional Animal Care and Use Committee of Sankyo (Tokyo, Japan) based on the guidelines provided by the American Institutional Animal Care and Use Committee.
3-MC was dissolved in corn oil and administered intraperitoneally to four rats of each strain at a dose of 2 mg/ kg/day for 3 days. PB was suspended in water containing 0.5% tragacanth and administered orally to four rats of each strain at a dose of 5 mg/kg/day for 3 days. In addition, four untreated rats of each strain served as controls. The rats were killed under ethyl ether anesthesia by exsanguination from the abdominal aorta 24 hr after the last administration. After removed, the livers were weighed and cut into pieces: some were fixed in 10% neutral buffered formalin and the rest were kept at -80°C until use. Hepatic microsomes were prepared in accordance with the methods described by Omura and Sato 11 with minor modifications. Protein concentration was assayed by the method reported by Lowry et al. 12 using bovine serum albumin as the standard. Odealkylation activities for both 7-ethoxyresorufin (EROD) and 7-pentoxyresorufin (PROD), mainly catalyzed by CYP1A and CYP2B, respectively, were assayed by measuring resorufin production 13 . Formalin-fixed, paraffinembedded sections (3 µm) were dewaxed and used for h i s t o m o r p h o l o g y ( h e m a t o x y l i n a n d e o s i n ) a n d immunohistochemistry (CYP1A1 and CYP2B1).
Results were expressed as mean and standard deviation (S.D.). Two-way analyses of variance with interaction (strain × treatment) and Fisher's protected Least Significant Difference (LSD) test were used to determine the presence of significant differences between groups 10 . All statistical analyses were performed using the SAS ® system (SAS Institute, Cary, NC). The level of statistical significance employed in all cases was P<0.05. Table 1 shows body weights and liver weights of Wistar and Mini rats on the day of sacrifice (day 3). Differences in body weights and absolute liver weights between treatmentmatched Wistar and Mini rats are shown: approximately 2-fold higher in Wistar rats than in Mini rats. Interestingly, the relative liver weights of Wistar rats were more than 10% higher than those of Mini rats. However, there were no significant differences in body and liver weights between the control and treated groups of either strain, and no hepatocyte hypertrophy was observed at the microscopic level (not shown), suggesting that the dose levels of the compounds used in this study were insufficient to induce liver hypertrophy. This was not surprising as it is known that much higher levels of chemicals for much longer administration periods are generally required to induce liver hypertrophy 14, 15 . Table 2 shows activities of 7-ethoxyresorufin (EROD) and 7-pentoxyresorufin O-dealkylation (PROD), reactions mainly catalyzed by CYP1A and CYP2B, respectively, by hepatic microsomes of untreated male Wistar and Mini rats or rats treated with 3-MC or PB. There were no significant differences in either EROD and PROD activities between untreated Wistar rats and untreated Mini rats. The EROD activity of 3-MC-treated Wistar rats was approximately 3.3-fold higher than that of the untreated Wistar rats, but this was not statistically significant. On the other hand, 3-MC administration caused an approximately 13-fold increase in the activity in Mini rats (P<0.05), and the value was also significantly higher than that of the 3-MC-treated Wistar rats. The PROD activities of PB-treated Wistar and Mini rats were increased more than 20-fold over the respective untreated controls (P<0.05), and the activity of the treated Mini rats was still higher than that of the treated Wistar rats, although there was only approximately a 1.6-fold difference. The enzyme activities were practically correlated with the immunohistochemistry featuring anti-CYP1A1 and anti-CYP 2B 1 a n tibo d ie s . Fig ur e 1 d e mo n str a te s th e immunohistochemistry using anti-CYP1A1 antibody. The positive area for anti-CYP1A1 was extended from just around the centrilobular area in the untreated Wistar and Mini rats (Figs. 1A, B) toward the mid-zonal (3-MC-treated Wistar rats, Fig. 1C ) or periportal areas (3-MC-treated Mini rats, Fig. 1D) , with an apparent difference between the treated groups. The immunohistochemistry using anti-CYP2B1 is shown in Fig. 2 . Compared with the untreated rats of both strains (Figs. 2A, B) , the positive area was extended from the centrilobular area toward the mid-zonal area in the PB-treated rats and the immunoreactivity was likely to be stronger (Figs. 2C, D) . However, unlike CYP1A1, we could hardly find strain differences in the immunoreactivity for CYP2B1 aside from a considerably strong immunoreaction in some of the centrilobular hepatocytes of the PB-treated Mini rats (Fig. 2D ). This might have been due to the strong induction of PROD activities at comparable levels in both the Wistar and Mini rats given PB.
In the preliminary experiment, we administered the same doses of PCN and acetone to both Wistar and Mini rats. We found that both CYP3A2 and CYP2E1, isoforms expressed more weakly and more abundantly in the untreated Mini rats, respectively 10 , are more strongly induced by hepatic enzyme inducers in Mini rats than in Wistar rats (not shown). This information, together with the results obtained in the present study, suggests that at least some of the hepatic microsomal CYP isoforms, especially CYP1A1, are induced more strongly in Mini rats than in Wistar rats, and further, that the magnitudes of enzyme induction do not depend on the expressions of the CYPs in the untreated rats of either strains. If these postulations are correct, GH may play a suppressive role in the hepatic enzyme induction. 
